Chesnara plc (LON:CSN – Get Free Report) shares hit a new 52-week high on Monday . The company traded as high as GBX 339.50 and last traded at GBX 334, with a volume of 95943 shares trading hands. The stock had previously closed at GBX 336.50.
Analysts Set New Price Targets
Several equities analysts have issued reports on the company. Berenberg Bank raised their price objective on Chesnara from GBX 333 to GBX 339 and gave the stock a “buy” rating in a report on Wednesday, April 8th. Royal Bank Of Canada reduced their target price on Chesnara from GBX 370 to GBX 360 and set an “outperform” rating for the company in a report on Wednesday, April 15th. Two research analysts have rated the stock with a Buy rating, Based on data from MarketBeat, the company has a consensus rating of “Buy” and a consensus price target of GBX 349.50.
Check Out Our Latest Stock Analysis on CSN
Chesnara Trading Down 0.5%
Insiders Place Their Bets
In other Chesnara news, insider Tom Howard sold 55,544 shares of the firm’s stock in a transaction on Monday, May 18th. The shares were sold at an average price of GBX 319, for a total transaction of £177,185.36. 0.82% of the stock is currently owned by corporate insiders.
Chesnara Company Profile
Chesnara (CSN.L) is a European life and pensions consolidator listed on the London Stock Exchange. It administers approximately one million policies and operates as Countrywide Assured in the UK, as The Waard Group and Scildon in the Netherlands, and as Movestic in Sweden.
Following a three-pillar strategy, Chesnara’s primary responsibility is the efficient administration of its customers’ life and savings policies, ensuring good customer outcomes and providing a secure and compliant environment to protect policyholder interests.
See Also
- Five stocks we like better than Chesnara
- NextEra’s Dominion Deal Could Put It at the Center of the AI Power Race
- Amazon Could Be About to Reap the Rewards of a Software Spending Boom
- Best Buy’s Turnaround Is Gaining Traction, But Wall Street Still Needs Proof
- AI Fears Hit Nebius Stock, But Has the Growth Thesis Changed?
Receive News & Ratings for Chesnara Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chesnara and related companies with MarketBeat.com's FREE daily email newsletter.
